Category Specific RSS

Categories: News

Novatti granted regulatory approval to issue Visa cards in New Zealand

Fresh off the launch of their Digital Payments Accelerator, Australian fintech company Novatti Group (ASX: NOV) has been granted approval in New Zealand to expand its credit card issuing services. 

The approval for ‘issuing and managing means of payments’ in New Zealand will provide commercial opportunities for Novatti to extend services to existing clients in NZ which already utilise their suite of payments tech, billing and international remittance services. 

 “Novatti’s model is to build platforms that provide the ability to scale. Obtaining regulatory licencing is core to this strategy,” said Novatti Managing Director, Peter Cook. 

“Where possible, Novatti aims to offer complementary services to existing Australian customers with a presence in New Zealand, and to capitalise on the deep relationships that already exist in New Zealand through Novatti’s business process automation subsidiary, Emersion.” 

New Zealand is one of three countries Emersion already has a notable presence, the others being Australia and Singapore, and recently launched on the Salesforce AppExchange, offering small businesses with billing automation and subscription payment services capabilities. 

Registration with the New Zealand Companies Office Financial Service Providers Register is a natural fit for Novatti which holds a Visa Principal Issuer license from Visa Inc, enabling them to issue prepaid Visa cards both physically and digitally. This issuing division has seen a notable rise in adoption since the onset of COVID-19 where card usage has dramatically increased with many businesses ceased accepting cash while also sales towards online mediums where possible. 

Through this expanded license to operate in New Zealand, local businesses will soon be able to utilise Novatti’s Digital Payments Accelerator which facilitates the issuing of up to 2,500 custom-branded Visa cards where usage can be restricted to customisable situations. 

 

*Owners of this website are shareholders in a company mentioned in this article and have been engaged by them to assist in investor communications

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US

Atomo Diagnostics (ASX:AT1) has secured a significant new order for its patented Pascal cassette, with…

1 week ago

June 2025 quarter CPI no roadblock to August RBA rate cut

The June 2025 quarter CPI data released today were cheered by mortgage holders and share…

2 weeks ago

Vection Secures $7.3M Defence Extension as AI Demand Strengthens

AI Gains Ground in Defence Sector As governments increase investment in defence technology, AI-powered tools…

3 weeks ago

Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology

Calix Limited (ASX:CXL) has taken a significant leap forward in developing Australia’s low-emissions steel value…

3 weeks ago

Harris Technology boosts retail margins in FY25 through growth of refurbished tech

Online tech retailer Harris Technology (ASX: HT8) has delivered a strong lift in gross product…

4 weeks ago

Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.

In a significant move set to reshape rapid diagnostics in the U.S., ASX-listed Lumos Diagnostics…

1 month ago